Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-04-23
1994-01-25
Shah, Mukund
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544284, 544287, 514260, C07D23991, C07D40310, A61K 31505, A01N 4354
Patent
active
052816044
ABSTRACT:
The invention provides novel 2,3,6 substituted quinazolinones of the formula ##STR1## wherein X, R and R.sup.6 are defined in the specification which have activity as angiotensin II (AII) antagonists.
REFERENCES:
patent: 5202322 (1993-04-01), Allen et al.
patent: 5238942 (1993-08-01), Chakravarty et al.
patent: 5240928 (1993-08-01), Allen et al.
Levin Jeremy I.
Venkatesan Aranapakam M.
American Cyanamid Company
Grumbling Matthew V.
Shah Mukund
Szatkowski Thomas S.
LandOfFree
Angiotensin II receptor blocking 2,3,6-substituted quinazolinone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II receptor blocking 2,3,6-substituted quinazolinone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II receptor blocking 2,3,6-substituted quinazolinone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-727908